PHI with Werlhof's disease
How does this condition affect your private health insurance?
Werlhof-Krankheit, also known as Immune Thrombocytopenia (ITP), is an autoimmune disorder characterized by a low platelet count. The immune system mistakenly attacks and destroys platelets, which are essential for blood clotting. This leads to symptoms such as easy bruising, petechiae, purpura, and bleeding from the nose or gums. In severe cases, internal bleeding, especially intracranial hemorrhage, can occur. ITP can be acute, particularly in children following viral infections, or chronic, often in adults, sometimes without a clear trigger. Diagnosis involves ruling out other causes of thrombocytopenia.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 40%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months for acute forms; ongoing for chronic forms.
Duration of Illness (Lifetime)
One-time event (acute, especially in children) or chronic disease (more common in adults).
Cost of Treatment (Initial)
Several thousands to tens of thousands of dollars, depending on severity and initial treatments (e.g., hospitalization, IVIg, steroids).
Cost of Treatment (Lifetime)
Tens of thousands to hundreds of thousands of dollars for chronic, refractory cases requiring long-term medication or procedures.
Mortality Rate
Low (typically <1-2%), primarily due to severe bleeding complications like intracranial hemorrhage.
Risk of Secondary Damages
Moderate (e.g., fatigue, depression, increased infection risk from immunosuppressive treatments, significant bruising, psychosocial impact).
Probability of Full Recovery
High (around 80%) for acute childhood ITP; variable (around 20-30% spontaneous remission, higher with treatment) for adult chronic ITP, though many achieve stable platelet counts with therapy.
Underlying Disease Risk
Moderate (can be associated with autoimmune diseases like SLE, viral infections like HIV or HCV, or lymphoproliferative disorders in a significant minority of cases).